
When a new antibody is generated, it needs to be characterized in several systems in order to be reliable. The target validation and cross-reactity studies are also required when entering a commercial applications of the antibody. This is necessary for validation of a humanized antibody aiming for a therapeutic use, but also with antibodies entering diagnostic testing.
Find more information regarding antibody target validation or cross-reactivity studies by immunohistochemistry here.
Find more information regarding antibody target validation or cross-reactivity studies by immunohistochemistry here.